Drugs during pregnancy and lactation : treatment options and risk assessment /

Mostrar otras versiones (3)

Drugs During Pregnancy and Lactation, 3rd Edition is a quick and reliable reference for all those working in disciplines related to fertility, pregnancy, lactation, child health and human genetics who prescribe or deliver medicinal products, and to those who evaluate health and safety risks. Each ch...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Schaefer, Christof (Editor ), Peters, P. W. J. (Paul W. J.) (Editor ), Miller, Richard K. (Richard Kermit), 1946- (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Alemán
Publicado: London, UK : Elsevier/Academic Press, [2015]
Edición:Third edition.
Colección:ClinicalKey.
Temas:
Pregnant women > Drug use.
Pregnant women > Medical care.
Obstetrical pharmacology > Handbooks, manuals, etc.
Fetus > Effect of drugs on > Handbooks, manuals, etc.
Newborn infants > Effect of drugs on > Handbooks, manuals, etc.
Chemotherapy.
Drugs > Side effects.
Newborn infants.
Drug Therapy
Contraindications
Drug-Related Side Effects and Adverse Reactions
Fetus > drug effects
Infant, Newborn
Lactation > drug effects
Pregnancy > drug effects
Femmes enceintes > Soins m�edicaux.
Pharmacologie obst�etricale > Guides, manuels, etc.
Nouveau-n�es > Effets des m�edicaments sur > Guides, manuels, etc.
Chimioth�erapie.
M�edicaments > Effets secondaires.
Nouveau-n�es.
MEDICAL > Gynecology & Obstetrics.
Newborn infants
Drugs > Side effects
Chemotherapy
Fetus > Effect of drugs on
Newborn infants > Effect of drugs on
Obstetrical pharmacology
Pregnant women > Drug use
Pregnant women > Medical care
Handbook
handbooks.
Handbooks and manuals
Handbooks and manuals.
Guides et manuels.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Cover; Drugs During Pregnancy and Lactation; Copyright; Contents; List of Contributors; Preface; Disclaimer; 1
  • General commentary on drug therapy and drug risks in pregnancy; 1.1 Introduction; 1.2 Development and health; 1.3 Reproductive stages; 1.4 Reproductive and developmental toxicology; 1.5 Basic principles of drug-induced reproductive and developmental toxicology; 1.6 Effects and manifestations; 1.7 Pharmacokinetics of drugs in pregnancy; 1.8 Mechanisms of developmental toxic agents; 1.9 Causes of developmental disorders; 1.10 Embryo/fetotoxic risk assessment and plausibility.
  • 1.11 Classification of drugs used in pregnancy1.12 Paternal use of medicinal products; 1.13 Communicating the risk of drug use in pregnancy; 1.14 Risk communication prior to pharmacotherapeutic choice; 1.15 Risk communication regarding the safety of drugs already used in pregnancy; 1.16 Teratology information centers; References; 2
  • Specific drug therapiesduring pregnancy; 2.1
  • Analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and antigout medications; 2.1.1 Paracetamol (acetaminophen); 2.1.2 Acetylsalicylic acid; 2.1.3 Pyrazolone compounds and phenylbutazone.
  • 2.4.9 Other antiemeticsSummary; References; 2.5
  • Gastro-intestinal medications, hypolipidemic agents and spasmolytics; 2.5.1 Antacids; 2.5.2 Sucralfate and pirenzepine; 2.5.3 H2 receptor antagonists; 2.5.4 Proton pump inhibitors; 2.5.5 Bismuth salts; 2.5.6 Helicobacter pylori therapy; 2.5.7 Digestives and carminatives; 2.5.8 Atropine and other anticholinergic spasmolytics; 2.5.9 Cholinergics; 2.5.10 Constipation during pregnancy; 2.5.11 Antidiarrheal agents; 2.5.12 Medications for inflammatory bowel disease; 2.5.13 Chenodeoxycholic acid and ursodeoxycholic acid; 2.5.14 Lipid lowering agents.

Ejemplares similares